Should a Patient on Aspirin Who Hits Their Head Get a CT Scan?
Yes, patients taking aspirin who sustain head trauma should undergo an initial head CT scan, as aspirin increases the risk of intracranial hemorrhage after head injury, though the absolute risk remains relatively low. 1
Initial CT Imaging is Indicated
The 2023 ACEP Clinical Policy guidelines clearly establish that antiplatelet agents like aspirin are associated with higher risk of intracranial hemorrhage (ICH) after mild head trauma, making the threshold for initial imaging very low 1. This recommendation applies to:
- Adults on aspirin who sustain blunt head trauma
- Patients with Glasgow Coma Scale (GCS) scores of 14-15
- Those with or without loss of consciousness (LOC) or post-traumatic amnesia
Key Evidence on Aspirin-Specific Risk
The most concerning data comes from a study of elderly patients (≥65 years) on low-dose aspirin with isolated mild head injury and GCS 15. Out of 100 patients, 4% developed delayed ICH, with one requiring neurosurgical decompression and another dying 1. This is notably higher than the risk seen with other anticoagulants.
However, context matters: A 2003 study found no significant difference in ICH rates between aspirin users and non-users in patients over 60 with mild-moderate head injury (24.5% vs 25.6%), with similar surgical intervention rates (4.5% vs 4.1%) 2.
After the Initial CT: What Next?
If Initial CT is Negative:
Patients who are neurologically intact with a normal initial head CT can generally be safely discharged without routine repeat imaging or mandatory observation 1. The data shows:
- Delayed ICH after negative initial CT is rare in aspirin users
- When delayed ICH occurs, it rarely requires neurosurgical intervention
- Most studies showing delayed ICH included observation periods, but these proved largely unnecessary
Important Caveats - Higher Risk Patients Requiring Caution:
Consider observation or repeat imaging for patients with:
- Age ≥65 years (highest risk group in aspirin studies)
- High-risk features: LOC, amnesia, or GCS <15 1
- Dual therapy: Aspirin plus anticoagulant (warfarin, NOACs)
- Poor social support or inability to return if symptoms develop
- Abnormal neurologic examination
Practical Management Algorithm
- Initial presentation: Obtain head CT for any aspirin user with head trauma
- If CT positive: Manage per standard TBI protocols
- If CT negative and patient neurologically intact:
- Low-risk (age <65, GCS 15, no LOC/amnesia): Discharge with clear return precautions
- Higher-risk (age ≥65, GCS <15, LOC/amnesia present): Consider brief observation period or repeat CT at 12-24 hours
- Discharge instructions: Critical given up to 5% risk of delayed ICH 1
Common Pitfalls to Avoid
- Don't automatically classify aspirin users as highest severity: Recent evidence suggests patients on low-dose aspirin with otherwise mild injuries (BIG 1 criteria) have significantly lower mortality and neurosurgery rates than other BIG 3 patients (2.2% vs 27%, p<0.001) 3
- Don't routinely withhold aspirin: With low incidence of delayed ICH, there's no strong argument for stopping aspirin unless supratherapeutic 1
- Don't skip the initial CT: Even patients with GCS 15 can harbor significant ICH (11.5% in aspirin users) 2
Evidence Quality Note
The guideline acknowledges limited patient numbers and potential selection bias in aspirin-specific studies 1. Most data comes from studies primarily examining warfarin or NOACs, with aspirin as a secondary focus. The 2023 ACEP guidelines explicitly state there were "not enough cases to make a recommendation for that particular antiplatelet agent" in their main analysis 1, though they do address it in supplementary discussion.
The bottom line: Initial CT is warranted; routine repeat imaging or observation is not necessary for most aspirin users with negative initial CT and normal neurologic exam, but elderly patients and those with high-risk features merit greater caution.